Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of impending graft rejection and relapse by lineage-specific chimerism analysis.

Methods in molecular medicine - 1 Jan 2007

Lion Thomas

Abstract excerpt

Molecular surveillance of hematopoietic chimerism has become part of the routine diagnostic program in patients after allogeneic stem cell transplantation. Chimerism testing permits early prediction and documentation of successful engraftment, and facilitates early detection of impending graft re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Lineage
Share to Cytodiagnosis
Share to Electrophoresis, Capillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Immunophenotyping

Share to Lymphocyte Subsets

Share to Recurrence

Share to Transplantation Chimera

Source

Identifiers

PMID: 17666752
DOI: 10.1007/978-1-59745-223-6_14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17666752-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of impending graft rejection and relapse by lineage-specific chimerism analysis.PMID 17666752Read ↗

Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A PerspectiveSemantic proximity Read ↗

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow TransplantationSemantic proximity Read ↗

Chimerism Monitoring Techniques after Hematopoietic Stem Cell Transplantation: An Overview of the Last 15 Years of InnovationsSemantic proximity Read ↗

Recent advances in quantitative chimerism analysis.Semantic proximity Read ↗

Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphismsSemantic proximity Read ↗

Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantationSemantic proximity Read ↗

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantationSemantic proximity Read ↗

Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism StudiesSemantic proximity Read ↗

Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaSemantic proximity Read ↗

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical ApplicationSemantic proximity Read ↗

Evaluation of Chimerism Testing by Next-Generation Sequencing Using Insertion/Deletion Markers: Analytical Validation and Examples of Clinical Utilization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.